Government urged to evaluate patient's access

Published: 2008-03-31 06:58:00

Updated: 2008-03-31 06:58:00

The Korean government needs to evaluate the effectiveness of new medicines in terms of patient's access, in addition to innovative concept and clinical significance, according to a report released by the Korea Institute for Health and Social Affairs.

The KIHSA's chief fellow Park Sylvia said t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK